Cargando…
RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization
BACKGROUND: The development of alternative anti-angiogenesis therapy for choroidal neovascularization (CNV) remains a great challenge. Nanoparticle systems have emerged as a new form of drug delivery in ocular diseases. Here, we report the construction and characterization of arginine-glycine-aspart...
Autores principales: | Zhang, Junxiu, Zhu, Jingyi, Zhao, Lingzhou, Mao, Ke, Gu, Qing, Li, Dongli, Zhao, Jinhua, Wu, Xingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254347/ https://www.ncbi.nlm.nih.gov/pubmed/34215269 http://dx.doi.org/10.1186/s12951-021-00939-9 |
Ejemplares similares
-
Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD
por: Mao, Ke, et al.
Publicado: (2017) -
Corrigendum to “Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD”
por: Mao, Ke, et al.
Publicado: (2020) -
Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles
por: Chu, Yongchao, et al.
Publicado: (2017) -
Intraocular RGD-Engineered Exosomes and Active Targeting of Choroidal Neovascularization (CNV)
por: Pollalis, Dimitrios, et al.
Publicado: (2022) -
The Antiangiogenic Effect of Sanguinarine Chloride on Experimental Choroidal Neovacularization in Mice via Inhibiting Vascular Endothelial Growth Factor
por: Zhang, Junxiu, et al.
Publicado: (2021)